Literature DB >> 21687950

Involvement of CD147 isoform‑4 in the proliferation of SiHa cells: a possible molecular mechanism of cervical cancer.

Yi Wu1, Xi Zhou, Peng-Sheng Zheng.   

Abstract

CD147, a multifunction glycoprotein of the immuno-globulin family, is associated with many types of tumors, and the overexpression of CD147 can enhance malignancy. However, the role of CD147 in cervical cancer remains unclear. In the present study, cervical cancer cells were found to express much more CD147 protein and isoform‑4 than normal cervical cells (P<0.05), suggesting that CD147 and isoform‑4 are involved in cervical cancers. Furthermore, we overexpressed the CD147 isoform‑4 (CD147‑4) in the cervical cancer cell line SiHa by transfection and found that CD147-4 promoted the proliferation of SiHa cells with a considerable proportion of cells in the S phase in which the expression of CIP2A, Plk and cyclin D1 was up-regulated while the expression of P27 was down-regulated. This may be one of the molecular mechanisms involved in cervical cancer progression by CD147.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21687950     DOI: 10.3892/or.2011.1345

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

Review 1.  EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.

Authors:  Dan-tong Liu
Journal:  Tumour Biol       Date:  2015-05-14

2.  Stimulation of GPR30 increases release of EMMPRIN-containing microvesicles in human uterine epithelial cells.

Authors:  Lindsey A Burnett; Mallory M Light; Pavni Mehrotra; Romana A Nowak
Journal:  J Clin Endocrinol Metab       Date:  2012-09-25       Impact factor: 5.958

3.  Purification of a polyclonal antibody against CD147 for ELISA using antigen‑immunoaffinity chromatography.

Authors:  Shuangshuang Liu; Shasha Li; Yang Zhang; Ye Wang; Yumeng Zhu; Bin Wang; Zhi-Nan Chen
Journal:  Mol Med Rep       Date:  2017-04-27       Impact factor: 2.952

4.  The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.

Authors:  Qingyuan Zhang; Hua Zhu; Zhouying Cui; Yuxiao Li; Jiaying Zhuo; Jingwei Ye; Zhihui Zhang; Zheng Lian; Qianqian Du; Kong-Nan Zhao; Lifang Zhang; Pengfei Jiang
Journal:  Biomolecules       Date:  2022-08-12

5.  Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.

Authors:  Shu-Hua Zhao; Yu Wang; Li Wen; Zhen-Bo Zhai; Zhen-Hua Ai; Nian-Ling Yao; Li Wang; Wen-Chao Liu; Bi-Liang Chen; Yu Li; Hong Yang
Journal:  J Transl Med       Date:  2013-04-08       Impact factor: 5.531

6.  HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.

Authors:  Qi Song; Juyi Wen; Weiping Li; Janxin Xue; Yufei Zhang; Hongyan Liu; Jixia Han; Tao Ning; Zejun Lu
Journal:  Cancer Sci       Date:  2022-02-22       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.